Open AccessPB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB‐CONTAINING THERAPY REGIMENS DEPENDING ON MAGE‐C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.
Author(s) -
Eleonora M.,
Larisa M.,
Vadim S.,
Maxim S.,
Maia F.,
Irina G.,
Sergey K.,
Anton S.,
Elisabeth M.,
Alexandra A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850648.81507.c0
Subject(s) - bortezomib , lenalidomide , multiple myeloma , medicine , oncology , daratumumab , bone marrow , gastroenterology